BTIG announced today that it will hold its annual Biotechnology Conference on Monday, August 8^th and Tuesday, August 9, 2022, in New York. The firm will host over 125 established and emerging healthcare company management teams for one-on-one investor meetings and thematic panel discussions with industry leaders. Panel themes will include biotech policy updates, KRAS targeting modalities, immuno-oncology, pulmonary medication development, cell therapy advancements, CNS AAV gene therapy developments, retinal disease developments, buyside biotech investor sentiment and more.

The conference will be hosted by:

• Julian Harrison, BTIG Biotechnology Analyst
• Bert Hazlett, BTIG Biotechnology Analyst
• Kaveri Pohlman, PhD, BTIG Biotechnology Analyst
• Thomas Shrader, PhD, CFA, BTIG Biotechnology Analyst
• Justin Zelin, BTIG Biotechnology Analyst
• Yun Zhong, PhD, BTIG Biotechnology Analyst
• Bhavin Patel, PharmD, BTIG Healthcare Strategy & Franchise Sales Specialist
• Kenny Storch, BTIG Healthcare Strategy & Franchise Sales Specialist

“Our biotechnology team has attracted some of the industry’s most respected thought leaders and corporate management teams to participate in our upcoming conference,” commented Ryan Serwin, CFA, Director of Research at BTIG. “We look forward to producing this hybrid event, where we bring together key public and private biotechnology companies with institutional investors to explore emerging innovations and discuss impactful trends across the industry.”

For more information about the conference, email info@btig.com. Please note that participants must be pre-registered to attend. To access BTIG insights, contact a firm representative or log in to www.btigresearch.com.

About BTIG

BTIG is a global financial services firm specializing in institutional trading, investment banking, research, and related brokerage services. With an extensive global footprint and more than 750 employees, BTIG, LLC and its affiliates operate out of 23 cities throughout the U.S., and in Europe, Asia, and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency, and commodities (futures, commodities, foreign exchange, interest rates, credit, and convertible and preferred securities). The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.

Disclaimer: https://www.btig.com/disclaimer. To learn more about BTIG, visit www.btig.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220808005217/en/